What is juli?
juli health specializes in managing chronic conditions via an AI-powered platform designed to personalize health tracking and recommendations. The company's core objective is to empower patients by enabling them to identify health triggers and implement small, impactful behavior changes. Their services are particularly tailored for individuals managing chronic conditions such as asthma and depression, with demonstrated efficacy supported by rigorous clinical trials. juli health places a strong emphasis on user engagement and retention to foster improved health outcomes.
How much funding has juli raised?
juli has raised a total of $3.8M across 1 funding round:
Angel/Seed
$3.8M
Angel/Seed (2022): $3.8M with participation from SoftBank Group, DvH Ventures, Norrsken, and Speedinvest
Key Investors in juli
SoftBank Group
SoftBank Group is a global technology holding company focused on innovation across telecommunications, internet services, AI, and robotics. Through its Vision Fund, it backs transformative technologies worldwide, aiming for long-term growth and industry leadership.
DvH Ventures
Dieter von Holtzbrinck Ventures is a European venture capital firm investing in early-stage companies. They provide hands-on support and strategic guidance, positioning themselves as partners to help founders grow their businesses.
Speedinvest
Speedinvest is a European venture capital fund investing in pre-Seed, Seed, and early-stage tech startups across sectors like Deep Tech, Fintech, and Health Tech. They offer capital and extensive network support to accelerate startup growth.
What's next for juli?
With the recent major strategic investment, juli health is poised for significant expansion and further development of its AI-driven health management solutions. This capital injection will likely fuel advancements in their platform's personalization capabilities and broaden their reach to more patients managing chronic conditions. The company's focus on clinical validation and user-centric design suggests a strategic direction towards deeper integration within healthcare ecosystems and potential partnerships to scale their impact. The enterprise-level backing indicates a strong market validation and confidence in juli health's long-term growth trajectory and its potential to reshape patient care.
See full juli company page
